This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
Prescribing Information for NGENLA▼(somatrogon) can be found here. Prescribing Information for Genotropin (somatropin) can be found here. Adverse event reporting information can be found at the bottom of the page.
Pfizer provides you and your patients with a wide range of ongoing patient and clinical support at every stage of treatment with NGENLA.
The services offered include:
• Dispensing and delivery
• Injection technique training
• Patient support calls
Pfizer offers a free and flexible home delivery service of NGENLA to patients, ensuring patients have continuity of access to their treatment.
Please contact the Pfizer freephone helpline on 0800 521249 for more information on this service.
When starting NGENLA treatment in a new patient, Pfizer’s Home Nurse Service provides in-home device training by trained nurses.
If a patient’s dose is split across 2 pens, we can offer a phone call the day before administration to offer support to the caregiver. This is available for the first 3 split doses following each prescription change.
• Injection technique training (unlimited)
• Telephone calls to conduct stock checks (unlimited)
Please contact the Pfizer freephone helpline on 0800 521249 for more information on this service.
The NGENLA team are here to support you with any queries. Find out how you can get in touch.
Find out how the Endocrine Helpline can support both you and your patients.
Find out information about the starter kits available to patients starting treatment with NGENLA.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2023 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021